FCGRT and neoplasm: Local immunity driven by reactivation of existing tumor-reactive T cells, TMZ-induced antigen release, and antigen presentation by activated microglia may directly contribute to the increased efficacy of FcRn-silenced IL-12Fc and also to an eventual broadening of the immune response.